Status:
UNKNOWN
Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia
Lead Sponsor:
Central South University
Conditions:
Schizophrenia
Metabolic Disturbance
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
cTBS is a promising novel intervention, which has strong potential on moderating disease syndrome. However, the most effective pattern of the cTBS is still under debate. Therefore, the investigators d...
Eligibility Criteria
Inclusion
- Patients diagnosed with schizophrenia in accordance with DSM-5
- BMI over 24
- Accepting antipsychotics stable treatment for more then 2 months
Exclusion
- Diagnosed with other mental disease in accordance with DSM-5
- Comorbid with other severe physiological disease
- Used antipsychotic, antidepressants, mood stabilizer, or other psychoactive substances before
- Drug or alcohol abuse
- Pregnant or lactating Contraindication to rTMS
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05358899
Start Date
June 1 2022
End Date
May 1 2023
Last Update
November 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Xiangya Hospital Central South University
Changsha, Hunan, China, 410000